These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7759392)

  • 1. Transferable production of PER-1 beta-lactamase in Pseudomonas aeruginosa.
    Danel F; Hall LM; Gur D; Akalin HE; Livermore DM
    J Antimicrob Chemother; 1995 Feb; 35(2):281-94. PubMed ID: 7759392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. OXA-16, a further extended-spectrum variant of OXA-10 beta-lactamase, from two Pseudomonas aeruginosa isolates.
    Danel F; Hall LM; Gur D; Livermore DM
    Antimicrob Agents Chemother; 1998 Dec; 42(12):3117-22. PubMed ID: 9835501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. OXA-15, an extended-spectrum variant of OXA-2 beta-lactamase, isolated from a Pseudomonas aeruginosa strain.
    Danel F; Hall LM; Gur D; Livermore DM
    Antimicrob Agents Chemother; 1997 Apr; 41(4):785-90. PubMed ID: 9087490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a novel extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
    Nordmann P; Ronco E; Naas T; Duport C; Michel-Briand Y; Labia R
    Antimicrob Agents Chemother; 1993 May; 37(5):962-9. PubMed ID: 8517722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OXA-11, an extended-spectrum variant of OXA-10 (PSE-2) beta-lactamase from Pseudomonas aeruginosa.
    Hall LM; Livermore DM; Gur D; Akova M; Akalin HE
    Antimicrob Agents Chemother; 1993 Aug; 37(8):1637-44. PubMed ID: 8215276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outbreak of PER-1 and diversity of β-lactamases among ceftazidime-resistant Pseudomonas aeruginosa clinical isolates.
    Qing Y; Cao KY; Fang ZL; Huang YM; Zhang XF; Tian GB; Huang X
    J Med Microbiol; 2014 Mar; 63(Pt 3):386-392. PubMed ID: 24398232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antibiotic susceptibility rates and beta-lactam resistance mechanisms of Pseudomonas aeruginosa strains].
    Aktaş Z; Satana D; Kayacan C; Can B; Gönüllü N; Küçükbasmacı O
    Mikrobiyol Bul; 2012 Jul; 46(3):386-97. PubMed ID: 22951651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A nosocomial outbreak of Pseudomonas aeruginosa isolates expressing the extended-spectrum beta-lactamase GES-2 in South Africa.
    Poirel L; Weldhagen GF; De Champs C; Nordmann P
    J Antimicrob Chemother; 2002 Mar; 49(3):561-5. PubMed ID: 11864961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PER-1- and OXA-10-like beta-lactamases in ceftazidime-resistant Pseudomonas aeruginosa isolates from intensive care unit patients in Istanbul, Turkey.
    Aktaş Z; Poirel L; Salcioğlu M; Ozcan PE; Midilli K; Bal C; Anğ O; Nordmann P
    Clin Microbiol Infect; 2005 Mar; 11(3):193-8. PubMed ID: 15715716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laboratory mutants of OXA-10 beta-lactamase giving ceftazidime resistance in Pseudomonas aeruginosa.
    Danel F; Hall LM; Livermore DM
    J Antimicrob Chemother; 1999 Mar; 43(3):339-44. PubMed ID: 10223588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. OXA-18, a class D clavulanic acid-inhibited extended-spectrum beta-lactamase from Pseudomonas aeruginosa.
    Philippon LN; Naas T; Bouthors AT; Barakett V; Nordmann P
    Antimicrob Agents Chemother; 1997 Oct; 41(10):2188-95. PubMed ID: 9333046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. OXA-28, an extended-spectrum variant of OXA-10 beta-lactamase from Pseudomonas aeruginosa and its plasmid- and integron-located gene.
    Poirel L; Girlich D; Naas T; Nordmann P
    Antimicrob Agents Chemother; 2001 Feb; 45(2):447-53. PubMed ID: 11158739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Pseudomonas aeruginosa isolates carrying the bla
    Liu CP; Chen TL; Wang NY; Chow SF; Lin JC; Yan TR
    J Microbiol Immunol Infect; 2017 Feb; 50(1):68-74. PubMed ID: 25648667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification and characterization of a new β-lactamase OXA-205 from Pseudomonas aeruginosa.
    Krasauskas R; Labeikytė D; Markuckas A; Povilonis J; Armalytė J; Plančiūnienė R; Kavaliauskas P; Sužiedėlienė E
    Ann Clin Microbiol Antimicrob; 2015 Nov; 14():52. PubMed ID: 26611758
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distribution of Ambler class A, B and D β-lactamases among Pseudomonas aeruginosa isolates.
    Tawfik AF; Shibl AM; Aljohi MA; Altammami MA; Al-Agamy MH
    Burns; 2012 Sep; 38(6):855-60. PubMed ID: 22348803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of NPS-1, a novel plasmid-mediated beta-lactamase, from two Pseudomonas aeruginosa isolates.
    Livermore DM; Jones CS
    Antimicrob Agents Chemother; 1986 Jan; 29(1):99-103. PubMed ID: 3089139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of ceftazidime/avibactam against problem Enterobacteriaceae and Pseudomonas aeruginosa in the UK, 2015-16.
    Livermore DM; Meunier D; Hopkins KL; Doumith M; Hill R; Pike R; Staves P; Woodford N
    J Antimicrob Chemother; 2018 Mar; 73(3):648-657. PubMed ID: 29228202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of Pseudomonas aeruginosa isolates producing VEB-type extended-spectrum beta-lactamases in the United Kingdom.
    Woodford N; Zhang J; Kaufmann ME; Yarde S; Tomas Mdel M; Faris C; Vardhan MS; Dawson S; Cotterill SL; Livermore DM
    J Antimicrob Chemother; 2008 Dec; 62(6):1265-8. PubMed ID: 18819973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OXA-type beta-lactamases among extended-spectrum cephalosporin-resistant Pseudomonas aeruginosa isolates in a university hospital in southern Taiwan.
    Yan JJ; Tsai SH; Chuang CL; Wu JJ
    J Microbiol Immunol Infect; 2006 Apr; 39(2):130-4. PubMed ID: 16604245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.